by Devices and Pharma | Apr 28, 2024 | Device_Submissions, Industry Information, Med-Devices, New devices, Premarket-Notification-510(k), Reg_Information, US-FDA
Understanding the 510(k) Premarket Notification Learn how the FDA’s 510(k) premarket notification system facilitates the introduction of new medical devices to the market, ensuring safety and compliance. Explore Our Services Streamlining FDA Approval Get Expert...
by Devices and Pharma | Apr 18, 2024 | Consumer Information, FDA Approvals, Industry News, Med-Devices, New devices, Product-Innovation
Edwards EVOQUE Tricuspid Valve Replacement System Artificial valve to address tricuspid valve regurgitation Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Edwards...
by Devices and Pharma | Apr 18, 2024 | FDA Approvals, Industry News, Med-Devices, New devices, Product-Innovation
Biotronic NRO's Prospera Spinal Cord Stimulation System Intended to treat for chronic, intractable back pain Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact...
by Devices and Pharma | Apr 18, 2024 | FDA Public Information, FDA Reports, Industry News, Med-Devices, Product-Innovation, US-FDA
CDRH Issues its 2024 Innovation Report Commitment to medical device innovation and safety Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Revolutionizing Medical...
by Devices and Pharma | Apr 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
FDA Approves New Antibiotic for Three Different Uses Zevtera effective against three bacterial infections Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact FDA...
by Devices and Pharma | Mar 31, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
New Treatment for Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine-Gynx (Elahere) Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In a significant...
